Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1989 3
1990 3
1994 1
1998 2
1999 1
2000 4
2001 11
2002 11
2003 11
2004 13
2005 16
2006 21
2007 16
2008 21
2009 19
2010 13
2011 23
2012 15
2013 16
2014 12
2015 15
2016 5
2017 3
2018 12
2019 7
2020 11
2021 7
2022 7
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

267 results

Results by year

Filters applied: . Clear all
Page 1
Bortezomib-induced peripheral neurotoxicity: an update.
Argyriou AA, Cavaletti G, Bruna J, Kyritsis AP, Kalofonos HP. Argyriou AA, et al. Among authors: kalofonos hp. Arch Toxicol. 2014 Sep;88(9):1669-79. doi: 10.1007/s00204-014-1316-5. Epub 2014 Jul 29. Arch Toxicol. 2014. PMID: 25069804 Review.
The Fire Within: NF-κB Involvement in Non-Small Cell Lung Cancer.
Dimitrakopoulos FD, Kottorou AE, Kalofonou M, Kalofonos HP. Dimitrakopoulos FD, et al. Among authors: kalofonos hp. Cancer Res. 2020 Oct 1;80(19):4025-4036. doi: 10.1158/0008-5472.CAN-19-3578. Epub 2020 Jul 2. Cancer Res. 2020. PMID: 32616502 Review.
Bevacizumab in the treatment of breast cancer.
Koutras AK, Fountzilas G, Makatsoris T, Peroukides S, Kalofonos HP. Koutras AK, et al. Among authors: kalofonos hp. Cancer Treat Rev. 2010 Feb;36(1):75-82. doi: 10.1016/j.ctrv.2009.10.007. Epub 2009 Nov 22. Cancer Treat Rev. 2010. PMID: 19932567 Review.
Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?
Papadimitriou K, Kountourakis P, Kottorou AE, Antonacopoulou AG, Rolfo C, Peeters M, Kalofonos HP. Papadimitriou K, et al. Among authors: kalofonos hp. Mol Diagn Ther. 2016 Dec;20(6):523-530. doi: 10.1007/s40291-016-0218-z. Mol Diagn Ther. 2016. PMID: 27392476 Review.
Angiogenesis as a therapeutic target in breast cancer.
Koutras AK, Starakis I, Lymperatou D, Kalofonos HP. Koutras AK, et al. Among authors: kalofonos hp. Mini Rev Med Chem. 2012 Oct;12(12):1230-8. doi: 10.2174/138955712802761988. Mini Rev Med Chem. 2012. PMID: 22512568 Review.
Early-Stage Breast Cancer in the Elderly: Confronting an Old Clinical Problem.
Dimitrakopoulos FI, Kottorou A, Antonacopoulou AG, Makatsoris T, Kalofonos HP. Dimitrakopoulos FI, et al. Among authors: kalofonos hp. J Breast Cancer. 2015 Sep;18(3):207-17. doi: 10.4048/jbc.2015.18.3.207. Epub 2015 Sep 24. J Breast Cancer. 2015. PMID: 26472970 Free PMC article. Review.
Epothilone-induced peripheral neuropathy: a review of current knowledge.
Argyriou AA, Marmiroli P, Cavaletti G, Kalofonos HP. Argyriou AA, et al. Among authors: kalofonos hp. J Pain Symptom Manage. 2011 Dec;42(6):931-40. doi: 10.1016/j.jpainsymman.2011.02.022. Epub 2011 May 31. J Pain Symptom Manage. 2011. PMID: 21621965 Free article. Review.
A review on oxaliplatin-induced peripheral nerve damage.
Argyriou AA, Polychronopoulos P, Iconomou G, Chroni E, Kalofonos HP. Argyriou AA, et al. Among authors: kalofonos hp. Cancer Treat Rev. 2008 Jun;34(4):368-77. doi: 10.1016/j.ctrv.2008.01.003. Epub 2008 Feb 20. Cancer Treat Rev. 2008. PMID: 18281158 Review.
267 results